Home / Grants / Grant

Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)

Updated

Cooperative agreement from the National Institutes of Health, open to small businesses. Closes Sep 10, 2027, 325 days left.

Be among the first to see new federal grants for small businesses
Only new grants that match, once a day. $29 a month or $290 a year, cancel any time.
Opportunity numberPAR-25-325
AgencyNational Institutes of Health
Funding typeCooperative agreement
FieldEducation, Health
Cost sharing or matchingNot required
Assistance listing93.393
PostedDec 13, 2024
ClosesSep 10, 2027 (325 days left)
Add the deadline toGoogle Calendar

Who can apply

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Description

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to support extramural research to investigate and mitigate challenges facing clinical assay development and subsequent analytical validation due to preanalytical variability in tumor tissue biopsies, blood biospecimens utilized as liquid biopsies", or other biospecimens as described in this NOFO.

Extramural research funded under this NOFO may include investigations of preanalytical variability associated with the procurement and study of small biopsies (core biopsies, small excision samples), blood utilized for "liquid biopsies", tissue swabs, tissue secretions, pleural and esophageal aspirates, feces, or bodily fluids like sweat, urine, CSF, breast milk and saliva. Investigator-designed experiments will explore how different biospecimen preanalytical conditions affect emerging and clinically relevant biomarkers quantified by a variety of testing platforms.

The results from this research program will improve the understanding of how analytical quantification of clinically relevant biomarkers is affected by variation in biospecimen collection, processing, and storage procedures. The overall goal is to expedite biomarker clinical assay development through evidence-based standardization of biopsy handling practices.

Full announcement and how to apply on Grants.gov

Education grants right now

There are 109 open federal grants in education that small businesses may apply for; 7 close within 30 days. The median award ceiling is $424,500. The agencies offering the most are National Institutes of Health and DOC NOAA - ERA Production. Grants in this field stay open a median of 1064 days; this one is open for 1001 days.

Who has won this program before

The largest grants and cooperative agreements under assistance listing 93.393 with funding activity since Oct 1, 2025, from USAspending.gov. Amounts are each award's total.

Other open grants in the same program

Under assistance listing 93.393, the federal program this grant is paid from.

Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
National Institutes of Health
Closes Nov 6, 2026 · 17 days left
Grant · Up to $350,000 an award · PAR-25-095
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
National Institutes of Health
Closes Nov 17, 2026 · 28 days left
Grant · Up to $200,000 an award · PAR-25-096
Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
National Institutes of Health
Closes Jan 7, 2027
Grant · PAR-25-167
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)
National Institutes of Health
Closes Jan 7, 2027
Grant · PAR-25-069
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)
National Institutes of Health
Closes Jan 7, 2027
Grant · PAR-25-070

More open grants from the National Institutes of Health

340 open grants from this agency accept small businesses, with $356.4 million in total program funding listed.

Nutrition Obesity Research Centers (NORCs) (P30 Clinical Trial Optional)
National Institutes of Health
Closes Oct 20, 2026 · today
Grant · Up to $750,000 an award · RFA-DK-27-120
Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical Trial Required)
National Institutes of Health
Closes Oct 22, 2026 · 2 days left
Grant · RFA-MH-27-140
GREGoRi Data Coordination and Outreach Center (U01, Clinical Trials Not Allowed)
National Institutes of Health
Closes Oct 30, 2026 · 10 days left
Cooperative agreement · Up to $1.2 million an award · RFA-HG-27-011
GREGoRi Innovation Projects (U01 Clinical Trial Optional)
National Institutes of Health
Closes Oct 30, 2026 · 10 days left
Cooperative agreement · Up to $500,000 an award · RFA-HG-27-013
GREGoRi Technology Integration Center (U01, Clinical Trials Optional)
National Institutes of Health
Closes Oct 30, 2026 · 10 days left
Cooperative agreement · Up to $2.2 million an award · RFA-HG-27-012

All open federal grants for small businesses